Disease · MONDO_0005906

peritonsillar abscess

6 sourcesdiseases-2026-09-18-0.1.0

Cite this record

ConductScience Library. peritonsillar abscess. Diseases, record MONDO_0005906. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/MONDO_0005906

On this page

Disease

Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.

Name: peritonsillar abscess; Open Targets
Open Targets ID: MONDO_0005906; Open Targets
Other names: Peritonsillar abscess (disorder), quinsy; Open Targets
MeSH: D000039; MeSH
NCI Thesaurus: C128322; NCI Thesaurus
Highest stage of its drugs: Approval, for 3 of its 7 drugs, from PMDA; Open Targets

Drugs7

The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

Drug	ChEMBL ID	Type	Open Targets' stage	Stage reported by	Reports	Of them trials	Trials shown here	Source
GARENOXACIN MESYLATE	CHEMBL3183451	Small molecule	Approval	PMDA	1	0	0	Drugs and targets
LASCUFLOXACIN	CHEMBL6068006	Small molecule	Approval	PMDA	1	0	0	Drugs and targets
SITAFLOXACIN	CHEMBL3989504	Small molecule	Approval	PMDA	1	0	0	Drugs and targets
CLINDAMYCIN	CHEMBL1753	Small molecule	Unknown	ClinicalTrials.gov	2	2	2	Drugs and targets
METRONIDAZOLE	CHEMBL137	Small molecule	Unknown	ClinicalTrials.gov	2	2	2	Drugs and targets
PENICILLIN G POTASSIUM	CHEMBL1223	Small molecule	Unknown	ClinicalTrials.gov	2	2	2	Drugs and targets
AMOXICILLIN/CLAVULANIC ACID	CHEMBL1697738	Small molecule	Unknown	ClinicalTrials.gov	1	1	1	Drugs and targets

Targets0

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

None in this release.

Trials3

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.

Trial	Title	Phase	Participants	Results first posted	Conditions	Drugs	Linked by	Source
NCT01255670	Penicillin and Metronidazole in Treatment of Peritonsillar Abscess	Not applicable	200	2021-05-11	Peritonsillar Abscess	METRONIDAZOLE, PENICILLIN G POTASSIUM	Its record names the disease	ClinicalTrials.gov
NCT03326661	Peritonsillar Abscess: Aspiration Versus Tonsillectomy a Chaud	Not applicable	128		Peritonsillar Abscess	CLINDAMYCIN, METRONIDAZOLE, PENICILLIN G POTASSIUM	Its record names the disease	ClinicalTrials.gov
NCT01715610	Assessing the Necessity of Prescribing Antibiotics (Clavulin or Clindamycin Versus Placebo) Post-peritonsillar Abscess Drainage	Not applicable	0		Peritonsillar Abscess	AMOXICILLIN/CLAVULANIC ACID, CLINDAMYCIN	Its record names the disease	ClinicalTrials.gov

Comparisons in its trials4

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

Comparison	Group 1, with the outcome	Group 2, with the outcome	Participants	Trial	Source
Penicillin and Metronidazole vs Penicillin and Placebo: Number of Participants With Recurrence of Peritonsillar Abscess	10 of 100	10 of 100	200	NCT01255670	Trial comparisons
Penicillin and Metronidazole vs Penicillin and Placebo: deaths from any cause	0 of 100	0 of 100	200	NCT01255670	Trial comparisons
Penicillin and Metronidazole vs Penicillin and Placebo: serious adverse events	0 of 100	0 of 100	200	NCT01255670	Trial comparisons
Penicillin and Metronidazole vs Penicillin and Placebo: Number of Participants Recovering From Peritonsillar Abscess	74 of 84	80 of 90	174	NCT01255670	Trial comparisons

Papers from its trials1

The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMID	Listed as	Trials listing it
26968881	DERIVED	1

Source PubMed

Data dates

The date of each source this release read.

Open Targets: 2026-09-18; Open Targets
Drug links and their checks, from Drugs and targets: 2026-09-18; Drugs and targets
ClinicalTrials.gov, from Trials: 2026-11-12; Trials
Comparisons, from Trial comparisons: 2026-03-23; Trial comparisons
PubMed, for the checks: 2026-11-06; PubMed
MeSH, for the checks: 2026-11-10; MeSH

Sources 6

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this disease from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0005906

GET https://conductscience.org/api/diseases/v1/MONDO_0005906/drugs

API reference For AI assistants